← Back to Search

Behavioural Intervention

Acupuncture for Breast Cancer

N/A
Waitlist Available
Led By Barbara Shay, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any patient diagnosed with stage 1-3 breast cancer who has finished chemotherapy 6 months prior and has residual CIPN symptoms graded as a 3/10 or higher on the numeric rating pain scale.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

To evaluate the effectiveness of Electro acupuncture (EA) for treatment of persistent painful CIPN symptoms in patients with stages 1-3 breast cancer treated with docetaxel chemotherapy 6 months prior

Eligible Conditions
  • Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
DASH (Disabilities of the arm, shoulder, hand)
LEFS (Lower extremity functional scale)
S-Lanss (short- Leads assessment of neuropathic symptoms and signs)
+1 more

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AcupunctureExperimental Treatment1 Intervention
Acupuncture will consist of acupuncture points ST36, LR3, LI4 bilaterally x 30 minutes, once a week over 6 weeks. ST36 will have EA with 2Hz at the maximum tolerated intensity (ES-130 Portable Japanese Electro-Acupuncture Device, UPC Medical Supplies Inc. South El Monte, CA, USA).
Group II: Sham AcupuncturePlacebo Group1 Intervention
Sham acupuncture (Streitberger Placebo Needles, Asiamed) uses the same points and treatment parameters but the placebo needle does not penetrate the skin and the current for EA is not turned on.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acupuncture
2011
Completed Phase 3
~1240

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,492 Total Patients Enrolled
3 Trials studying Breast Cancer
4,577 Patients Enrolled for Breast Cancer
CancerCare ManitobaOTHER
28 Previous Clinical Trials
5,638 Total Patients Enrolled
4 Trials studying Breast Cancer
682 Patients Enrolled for Breast Cancer
Barbara Shay, PhDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
"Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy"
Barbara Shay 2016. ""Electro Acupuncture in the Treatment and Management of Chemotherapy Induced Peripheral Neuropathy"". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02821442.
All > Neuropathy > Peripheral Neuropathy
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top